Pharma giants pressed by Senate Democrats over Trump pricing deals
Source: SeekingAlpha
2026-03-06 10:45:02 ET
More on Pfizer, Merck, etc.
- Pfizer: Obesity Hype And Vaccine Policy Shocks
- AbbVie: Stabilizes Near $233 While Testing Resistance
- Pfizer's Portfolio Renewal In Progress - High Yields For The Patient
- China approves Pfizer’s GLP-1 drug for weight management, intensifying market competition
- J&J wins FDA nod for multiple myeloma therapy
Read the full article on Seeking Alpha
For further details see:
Pharma giants pressed by Senate Democrats over Trump pricing deals
Bristol-Myers Squibb Company
NASDAQ: BMY
BMY Trading
0.33% G/L:
$59.135 Last:
3,589,652 Volume:
$59.67 Open:
BMY Latest News
March 09, 2026 06:59:00 am
Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma
BMY Stock Data
$123,325,918,376
2,034,328,000
N/A
1394
N/A
Pharmaceuticals
Healthcare
US
Princeton
